Skip to content

Organon logo

Main menu
      • Our focus
      • Products list
      • Patient support programs
      • Organon Pro for healthcare professionals
      • Safety data sheets
      • Product patents
      • Leadership team
      • Board of Directors
      • Corporate governance
    • Business development
    • Our culture
    • Our stories
    • Policies & positions
    • Environmental, social & governance
      • Our Suppliers
      • Supplier relationship management
    • Media
    • News
    • Investor relations overview
    • Events & presentations
    • SEC filings
    • Financial Information
    • Investor resources
  • Careers

Contact us

Visit Organon's Twitter Opens a new window Visit Organon's Facebook Opens a new window Visit Organon's LinkedIn Opens a new window Visit Organon's Instagram Opens a new window Visit Organon's YouTube Opens a new window

Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:
Her story

Enrica’s journey with migraine

A story of resilience and advocacy

November 20, 2024

Share this article

Enrica sitting in car with sunglasses on, smiling

Meet Enrica

Enrica is a wife and mother of two, living in Italy, where she balances family life and her love of travel with her role as a member of the Medical Affairs team at Organon. Living with severe migraine has led her to make several career shifts over the years – her dream of being a theater actress was too demanding on her physical health, while her work as a clinical psychologist was too taxing emotionally. Enrica eventually found her place at Organon, a global healthcare company whose mission is to improve the health of women throughout their lives, where she helps to further a culture of openness and understanding around health challenges.

Early Days with Migraine

Enrica’s migraine attacks began as a little girl, presenting primarily as abdominal pain and frequent vomiting. She also experienced nausea, fatigue, musculoskeletal pain and cognitive issues, as well as sensitivity to light, sound, smells and even touch. While her mother believed something serious was at play, others were skeptical. The constant doubt impacted Enrica’s self-esteem, leaving her feeling misunderstood and causing her to hide her suffering from many in her life.

It wasn’t until she was 24 that she received a diagnosis from a specialist after her family doctor suggested migraine as a possible cause.

Losing Trust, Gaining Confidence and Taking Action

Following her diagnosis, different treatments failed to provide relief, despite doctors insisting that they should be working. This left Enrica feeling dismissed, unheard and isolated, eroding her trust in the medical system. Her mental health was also greatly impacted – she suffered from depression, anxiety and even panic attacks.  

The turning point came when she realized that education gave her the power to ask for what she needed. She began learning about clinical studies, new therapies and alternative treatments. As she grew more confident in asking for what she needed, doctors began to listen.

Enrica’s determination only strengthened when she became a mother. She wanted to take control of her health so that her children didn’t see her trapped in anger, depression and fear for the future. Enrica became a strong advocate for her health, which finally led her to a new treatment program that helped her gain control of the condition, migraine, and improve her quality of life.

Discovering the Larger Impact

Through her research and talking to others, Enrica also learned that women are three times as likely as men to experience migraine*. This discovery struck a personal chord when she realized that her mother and two aunts had also suffered from migraine for years but were never formally diagnosed. It became clear to her that many women’s experiences with this condition are overlooked or dismissed, much like her own had been.

Surrounded by support

At Organon, Enrica feels “safe” sharing her story with managers and with colleagues. When a migraine attack hits, Enrica tells her team it’s a “migraine day” and they know now what to expect. Her colleagues offer support, and even share a laugh when her migraine causes her to mix up words, creating a sense of camaraderie and understanding.

Her husband and family have been great sources of comfort, as have advocacy communities and online communities. Within these patient communities, Enrica felt free from the stigma she often faced, allowing her to share her story openly and learn from others impacted by migraine.

Today, Enrica has transformed her struggles into a source of strength. She shares her story to not only empower herself but inspire others facing similar challenges. Her journey is a testament to the power of resilience and advocacy in overcoming obstacles and making a difference.


*Sex and gender differences in migraines: a narrative review. U.S. National Institutes of Health’s National Library of Medicine (NIH/NLM). https://pmc.ncbi.nlm.nih.gov/articles/PMC9176156/. Published June 8, 2022. Last accessed August 26, 2024.

Connect with us on social

Linkedin icon Opens a new window Twitter icon Opens a new window Facebook icon Opens a new window Instagram icon Opens a new window YouTube icon Opens a new window
Organon logo

Company

  • About us
  • Our Leaders
  • Environmental, social & governance
  • Policies & positions

Resources

  • Patient resources
  • Investor relations
  • Media
  • Organon Pro for healthcare professionals

Contact us

  • Contact information
  • Global locations
  • Forward-Looking Statement
  • Cookie policy
  • Privacy Policy
  • Consumer Health Data Policy
  • Terms of Use
  • Sitemap
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies. This site is intended for residents of the United States.
Level Access website accessibility icon. Opens a new window TRUSTe Opens a new window

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

Any statements set forth on this website that are not historical facts are considered “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of Organon’s management and are subject to significant risks and uncertainties. By their nature, forward-looking statements involve risks and uncertainties because they depend on circumstances that may or may not occur in the future. Although these statements are based on assumptions that we believe are reasonable when made, we caution you that forward-looking statements are not guarantees of future performance and you should not place undue reliance on them.

Organon undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s other filings with the Securities and Exchange Commission (SEC), including its registration statement on Form 10, available at the SEC’s Internet site (www.sec.gov Opens a new window).

Decline Accept